Categories October Surprise 2024 FGFR and Biomarker Testing | BALVERSAĀ® (erdafitinib) HCP Post author By Post date June 24, 2025 Learn how FGFR biomarker testing helps identify patients with metastatic urothelial carcinoma who are eligible for BALVERSAĀ®. See Full Safety and Prescribing Information.